^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    DetermaMx™

    Company:
    Oncocyte
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    DetermaMx™ “Tumor Informed” a blood‐based recurrence monitoring test will launch as RUO for pharma trials. It could identify the early onset of a secondary tumor post treatment for an initial cancer earlier than imaging and thus, assist physicians in managing recurring tumors early when they are most curable.
    Method:
    Blood based